Skip to main content
Top
Published in: Inflammation 6/2016

01-12-2016 | ORIGINAL ARTICLE

Beneficial Effects of Exogenous Melatonin in Acute Staphylococcus aureus and Escherichia coli Infection-Induced Inflammation and Associated Behavioral Response in Mice After Exposure to Short Photoperiod

Authors: Biswadev Bishayi, Rana Adhikary, Ajeya Nandi, Sahin Sultana

Published in: Inflammation | Issue 6/2016

Login to get access

Abstract

The administration of melatonin during acute bacterial infection was evaluated in this study. Mice pre-exposed to normal photoperiodic (NP), short photoperiodic (SP), and long photoperiodic (LP) day lengths were infected separately with live Staphylococcus aureus (5 × 106 cells/ml) or Escherichia coli (2.5 × 107 colony-forming units/ml) and treated with melatonin (10 mg/kg body weight). Behavioral studies were performed before bacterial infection and after melatonin administration. In mice pre-exposed to SP, exogenous melatonin administration resulted in better clearance of bacteria from blood and behavioral improvement. Reduced glutathione content and superoxide dismutase activities were increased, with concomitant decrease in lipid peroxidation content and catalase activities in the liver, brain, and spleen after exogenous melatonin administration. The overproduction of tumor necrosis factor-α, interferon-γ, and interleukin-6 during acute bacterial infection in mice exposed to different photoperiods was probably regulated by the administration of exogenous melatonin, by reducing neutrophil recruitment to spleen, expression of inducible nitric oxide synthase and cyclooxygenase-2 in hypothalamus, and C-reactive protein in the serum, and was also associated with improved behavioral response. Photoperiodic variations in inflammatory and oxidative stress markers might be correlated to serum melatonin and corticosterone levels. This study suggests that the administration of melatonin during SP exposure is protective in infection-induced inflammation than NP and LP exposure.
Literature
1.
go back to reference Tan, D.X., L.C. Manchester, S. Burkhardt, R.M. Sainz, J.C. Mayo, R. Kohen, E. Shohami, Y.S. Huo, R. Hardeland, and R.J. Reiter. 2001. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB Journal 15: 2294–2296.PubMed Tan, D.X., L.C. Manchester, S. Burkhardt, R.M. Sainz, J.C. Mayo, R. Kohen, E. Shohami, Y.S. Huo, R. Hardeland, and R.J. Reiter. 2001. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB Journal 15: 2294–2296.PubMed
2.
go back to reference Guerrero, J.M., and R.J. Reiter. 2002. Melatonin-immune system relationships. Current Topics in Medicinal Chemistry 2: 167–180.CrossRefPubMed Guerrero, J.M., and R.J. Reiter. 2002. Melatonin-immune system relationships. Current Topics in Medicinal Chemistry 2: 167–180.CrossRefPubMed
3.
go back to reference Radogna, F., M. Diederich, and L. Ghibelli. 2010. Melatonin: a pleiotropic molecule regulating inflammation. Biochemical Pharmacology 80: 1844–1852.CrossRefPubMed Radogna, F., M. Diederich, and L. Ghibelli. 2010. Melatonin: a pleiotropic molecule regulating inflammation. Biochemical Pharmacology 80: 1844–1852.CrossRefPubMed
4.
go back to reference Moore, R.Y. 1997. Circadian rhythms: basic neurobiology and clinical applications. Annual Review of Medicine 48: 253–266.CrossRefPubMed Moore, R.Y. 1997. Circadian rhythms: basic neurobiology and clinical applications. Annual Review of Medicine 48: 253–266.CrossRefPubMed
5.
6.
go back to reference Reiter, R.J., J.R. Calvo, M. Karbownik, W. Qi, and D.X. Tan. 2000. Melatonin and its relation to the immune system and inflammation. Annals of the New York Academy of Sciences 917: 376–386.CrossRefPubMed Reiter, R.J., J.R. Calvo, M. Karbownik, W. Qi, and D.X. Tan. 2000. Melatonin and its relation to the immune system and inflammation. Annals of the New York Academy of Sciences 917: 376–386.CrossRefPubMed
7.
go back to reference Maestroni, G.J. 1993. The immunoneuroendocrine role of melatonin. Journal of Pineal Research 14: 1–10.CrossRefPubMed Maestroni, G.J. 1993. The immunoneuroendocrine role of melatonin. Journal of Pineal Research 14: 1–10.CrossRefPubMed
8.
go back to reference Pandi-Perumal, S.R., I. Trakht, V. Srinivasan, D.W. Spence, G.J. Maestroni, N. Zisapel, and D.P. Cardinali. 2008. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Progress in Neurobiology 85: 335–353.CrossRefPubMed Pandi-Perumal, S.R., I. Trakht, V. Srinivasan, D.W. Spence, G.J. Maestroni, N. Zisapel, and D.P. Cardinali. 2008. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Progress in Neurobiology 85: 335–353.CrossRefPubMed
9.
go back to reference Carrillo-Vico, A., J.M. Guerrero, P.J. Lardone, and R.J. Reiter. 2005. A review of the multiple actions of melatonin on the immune system. Endocrine 27: 189–200.CrossRefPubMed Carrillo-Vico, A., J.M. Guerrero, P.J. Lardone, and R.J. Reiter. 2005. A review of the multiple actions of melatonin on the immune system. Endocrine 27: 189–200.CrossRefPubMed
10.
go back to reference Lopez-Gonzalez, M.A., J.R. Calvo, J.J. Segura, and J.M. Guerrero. 1993. Characterization of melatonin binding sites in human peripheral blood neutrophils. Biotechnology Therapeutics 4: 253–262.PubMed Lopez-Gonzalez, M.A., J.R. Calvo, J.J. Segura, and J.M. Guerrero. 1993. Characterization of melatonin binding sites in human peripheral blood neutrophils. Biotechnology Therapeutics 4: 253–262.PubMed
11.
go back to reference Barjavel, M.J., Z. Mamdouh, N. Raghbate, and O. Bakouche. 1998. Differential expression of the melatonin receptor in human monocytes. Journal of Immunology 160: 1191–1197. Barjavel, M.J., Z. Mamdouh, N. Raghbate, and O. Bakouche. 1998. Differential expression of the melatonin receptor in human monocytes. Journal of Immunology 160: 1191–1197.
12.
go back to reference Lopez-Gonzalez, M.A., J.R. Calvo, C. Osuna, and J.M. Guerrero. 1992. Interaction of melatonin with human lymphocytes: evidence for binding sites coupled to potentiation of cyclic AMP stimulation by vasoactive intestinal peptide and activation of cyclic GMP production. Journal of Pineal Research 12: 97–104.CrossRefPubMed Lopez-Gonzalez, M.A., J.R. Calvo, C. Osuna, and J.M. Guerrero. 1992. Interaction of melatonin with human lymphocytes: evidence for binding sites coupled to potentiation of cyclic AMP stimulation by vasoactive intestinal peptide and activation of cyclic GMP production. Journal of Pineal Research 12: 97–104.CrossRefPubMed
13.
go back to reference Carrillo-Vico, A., J.R. Calvo, P. Abreu, P.J. Lardone, S. García-Mauriño, R.J. Reiter, and J.M. Guerrero. 2004. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB Journal 18: 537–539.PubMed Carrillo-Vico, A., J.R. Calvo, P. Abreu, P.J. Lardone, S. García-Mauriño, R.J. Reiter, and J.M. Guerrero. 2004. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB Journal 18: 537–539.PubMed
14.
go back to reference Sánchez-Barceló, E.J., M.D. Mediavilla, D.X. Tan, and R.J. Reiter. 2010. Clinical uses of melatonin: evaluation of human trials. Current Topics in Medicinal Chemistry 17: 2070–2095.CrossRef Sánchez-Barceló, E.J., M.D. Mediavilla, D.X. Tan, and R.J. Reiter. 2010. Clinical uses of melatonin: evaluation of human trials. Current Topics in Medicinal Chemistry 17: 2070–2095.CrossRef
15.
go back to reference Tomás-Zapico, C., and A. Coto-Montes. 2007. Melatonin as antioxidant under pathological processes. Recent Patents on Endocrine Metabolic and Immune Drug Discovery. 1: 63–82.CrossRef Tomás-Zapico, C., and A. Coto-Montes. 2007. Melatonin as antioxidant under pathological processes. Recent Patents on Endocrine Metabolic and Immune Drug Discovery. 1: 63–82.CrossRef
16.
go back to reference Anisimov, V.N. 2003. Effects of exogenous melatonin—A review. Toxicologic Pathology 31: 589–603.PubMed Anisimov, V.N. 2003. Effects of exogenous melatonin—A review. Toxicologic Pathology 31: 589–603.PubMed
17.
go back to reference Walton, J.C., Z.M. Weil, and R.J. Nelson. 2011. Influence of photoperiod on hormones, behavior, and immune function. Frontiers in Neuroendocrinology 32: 303–319.CrossRefPubMed Walton, J.C., Z.M. Weil, and R.J. Nelson. 2011. Influence of photoperiod on hormones, behavior, and immune function. Frontiers in Neuroendocrinology 32: 303–319.CrossRefPubMed
18.
go back to reference McWhir, J., A.E. Schnieke, R. Ansell, H. Wallace, A. Colman, A.R. Scott, and A.J. Kind. 1996. Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background. Nature Genetics 14: 223–226.CrossRefPubMed McWhir, J., A.E. Schnieke, R. Ansell, H. Wallace, A. Colman, A.R. Scott, and A.J. Kind. 1996. Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background. Nature Genetics 14: 223–226.CrossRefPubMed
19.
go back to reference Carrillo-Vico, A., P.J. Lardone, L. Naji, J.M. Fernández-Santos, I. Martín-Lacave, J.M. Guerrero, and J.R. Calvo. 2005. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. Journal of Pineal Research 39: 400–408.CrossRefPubMed Carrillo-Vico, A., P.J. Lardone, L. Naji, J.M. Fernández-Santos, I. Martín-Lacave, J.M. Guerrero, and J.R. Calvo. 2005. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. Journal of Pineal Research 39: 400–408.CrossRefPubMed
20.
go back to reference Borges, L.S., A. Dermargos, E.P. Junior, E. Weimann, R.H. Lambertucci, and E. Hatanaka. 2015. Melatonin decreases muscular oxidative stress and inflammation induced by strenuous exercise and stimulates growth factor synthesis. Journal of Pineal Research 58: 166–172.CrossRef Borges, L.S., A. Dermargos, E.P. Junior, E. Weimann, R.H. Lambertucci, and E. Hatanaka. 2015. Melatonin decreases muscular oxidative stress and inflammation induced by strenuous exercise and stimulates growth factor synthesis. Journal of Pineal Research 58: 166–172.CrossRef
21.
go back to reference Reiter, R.J. 1991. Melatonin: the chemical expression of darkness. Molecular and Cellular Endocrinology 79: 153–158.CrossRef Reiter, R.J. 1991. Melatonin: the chemical expression of darkness. Molecular and Cellular Endocrinology 79: 153–158.CrossRef
22.
go back to reference Reiter, R.J. 1991. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Reviews 12: 151–180.CrossRefPubMed Reiter, R.J. 1991. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Reviews 12: 151–180.CrossRefPubMed
23.
go back to reference Stehle, J.H., C. von-Goll, and H.W. Korf. 2003. Melatonin: a clock-output, a clock-input. Journal of Endocrinology 15: 383–389. Stehle, J.H., C. von-Goll, and H.W. Korf. 2003. Melatonin: a clock-output, a clock-input. Journal of Endocrinology 15: 383–389.
24.
go back to reference Yellon, S.M., and L.T. Tran. 2002. Photoperiod, reproduction, and immunity in select strains of inbred mice. Journal of Biological Rhythms 17: 65–75.CrossRefPubMed Yellon, S.M., and L.T. Tran. 2002. Photoperiod, reproduction, and immunity in select strains of inbred mice. Journal of Biological Rhythms 17: 65–75.CrossRefPubMed
25.
go back to reference Javier, E., J.A. Pariente, and A.B. Rodríguez. 2012. Oxidative stress and immunosenescence: therapeutic effects of melatonin. Oxidative Medicine and Cellular Longevity. doi:10.1155/2012/670294. Javier, E., J.A. Pariente, and A.B. Rodríguez. 2012. Oxidative stress and immunosenescence: therapeutic effects of melatonin. Oxidative Medicine and Cellular Longevity. doi:10.​1155/​2012/​670294.
26.
go back to reference Cuzzocrea, S., B. Zingarelli, E. Gilad, P. Hake, A.L. Salzman, and C. Szabó. 1997. Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. Journal of Pineal Research 23: 106–116.CrossRefPubMed Cuzzocrea, S., B. Zingarelli, E. Gilad, P. Hake, A.L. Salzman, and C. Szabó. 1997. Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. Journal of Pineal Research 23: 106–116.CrossRefPubMed
27.
go back to reference Srinivasan, V., S.R. Pandi-Perumal, D.W. Spence, H. Kato, and D.P. Cardinali. 2010. Melatonin in septic shock: some recent concepts. Journal of Critical Care 25: 656–e1.CrossRefPubMed Srinivasan, V., S.R. Pandi-Perumal, D.W. Spence, H. Kato, and D.P. Cardinali. 2010. Melatonin in septic shock: some recent concepts. Journal of Critical Care 25: 656–e1.CrossRefPubMed
28.
go back to reference Srinivasan, V., M. Mohamed, and H. Kato. 2012. Melatonin in bacterial and viral infections with focus on sepsis: a review. Recent Patents on Endocrine Metabolic and Immune Drug Discoveries 6: 30–39.CrossRef Srinivasan, V., M. Mohamed, and H. Kato. 2012. Melatonin in bacterial and viral infections with focus on sepsis: a review. Recent Patents on Endocrine Metabolic and Immune Drug Discoveries 6: 30–39.CrossRef
29.
go back to reference Maestroni, G.J. 1999. Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer. Advances in Experimental Medicine and Biology 467: 217–226.CrossRefPubMed Maestroni, G.J. 1999. Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer. Advances in Experimental Medicine and Biology 467: 217–226.CrossRefPubMed
31.
go back to reference Markus, R.P., and Z.S. Ferreira. 2011. The immune-pineal axis: the role of pineal and extra-pineal melatonin in modulating inflammation. Advances in Neuroimmunobiology 1: 95–104. Markus, R.P., and Z.S. Ferreira. 2011. The immune-pineal axis: the role of pineal and extra-pineal melatonin in modulating inflammation. Advances in Neuroimmunobiology 1: 95–104.
32.
go back to reference Prendergast, B.J., A.K. Hotchkiss, S.D. Bilbo, S.G. Kinsey, and R.J. Nelson. 2003. Photoperiodic adjustments in immune function protect Siberian hamsters from lethal endotoxemia. Journal of Biological Rhythms 18: 51–62.CrossRefPubMed Prendergast, B.J., A.K. Hotchkiss, S.D. Bilbo, S.G. Kinsey, and R.J. Nelson. 2003. Photoperiodic adjustments in immune function protect Siberian hamsters from lethal endotoxemia. Journal of Biological Rhythms 18: 51–62.CrossRefPubMed
33.
go back to reference Tekbas, O.F., R. Ogu, A. Korkmaz, A. Kilic, and R.J. Reiter. 2008. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule. Journal of Pineal Research 44: 222–226.CrossRefPubMed Tekbas, O.F., R. Ogu, A. Korkmaz, A. Kilic, and R.J. Reiter. 2008. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule. Journal of Pineal Research 44: 222–226.CrossRefPubMed
34.
go back to reference Korkmaz, A., R.J. Reiter, T. Topal, L.C. Manchester, S. Oter, and D.X. Tan. 2005. Melatonin: an established antioxidant worthy of use in clinical trials. Molecular Medicine 15: 43–50. Korkmaz, A., R.J. Reiter, T. Topal, L.C. Manchester, S. Oter, and D.X. Tan. 2005. Melatonin: an established antioxidant worthy of use in clinical trials. Molecular Medicine 15: 43–50.
35.
go back to reference Escames, G., D. Acuña-Castroviejo, L.C. López, D.X. Tan, M.D. Maldonado, M. Sánchez- Hidalgo, et al. 2006. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. Journal of Pharmaceutical Pharmacology 58: 1153–1165.CrossRef Escames, G., D. Acuña-Castroviejo, L.C. López, D.X. Tan, M.D. Maldonado, M. Sánchez- Hidalgo, et al. 2006. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. Journal of Pharmaceutical Pharmacology 58: 1153–1165.CrossRef
36.
go back to reference Pandi-Perumal, S.R., and D. P. Cardinali. 2006. Melatonin: biological basis of its function in health and disease. 4th ed. Landes Bioscience. Pandi-Perumal, S.R., and D. P. Cardinali. 2006. Melatonin: biological basis of its function in health and disease. 4th ed. Landes Bioscience.
37.
go back to reference Rinaldi, S., F. Landucci, and A.R. de Gaudio. 2009. Antioxidant therapy in critically septic patients. Current Drug Targets 10: 872–880.CrossRefPubMed Rinaldi, S., F. Landucci, and A.R. de Gaudio. 2009. Antioxidant therapy in critically septic patients. Current Drug Targets 10: 872–880.CrossRefPubMed
38.
go back to reference Yonei, Y., A. Hattori, K. Tsutsui, M. Okawa, and B. Ishizuka. 2010. Effects of melatonin: basics studies and clinical applications. Anti-Aging Medicine 7: 85–91.CrossRef Yonei, Y., A. Hattori, K. Tsutsui, M. Okawa, and B. Ishizuka. 2010. Effects of melatonin: basics studies and clinical applications. Anti-Aging Medicine 7: 85–91.CrossRef
39.
go back to reference Srinivasan, V., G.J. Maestroni, D.P. Cardinali, A.I. Esquifino, S.R. Pandi-Perumal, and S.C. Miller. 2005. Melatonin, immune function and aging. Immunity and Ageing 2: 17.CrossRefPubMedPubMedCentral Srinivasan, V., G.J. Maestroni, D.P. Cardinali, A.I. Esquifino, S.R. Pandi-Perumal, and S.C. Miller. 2005. Melatonin, immune function and aging. Immunity and Ageing 2: 17.CrossRefPubMedPubMedCentral
40.
go back to reference Pevet, P., B. Bothorel, H. Slotten, and M. Saboureau. 2002. The chronobiotic properties of melatonin. Cell and Tissue Research 309: 183–191.CrossRefPubMed Pevet, P., B. Bothorel, H. Slotten, and M. Saboureau. 2002. The chronobiotic properties of melatonin. Cell and Tissue Research 309: 183–191.CrossRefPubMed
41.
go back to reference Ebihara, S., T. Marks, D.J. Hudson, and M. Menaker. 1986. Genetic control of melatonin synthesis in the pineal gland of the mouse. Science 231: 491–492.CrossRefPubMed Ebihara, S., T. Marks, D.J. Hudson, and M. Menaker. 1986. Genetic control of melatonin synthesis in the pineal gland of the mouse. Science 231: 491–492.CrossRefPubMed
42.
go back to reference Maestroni, G.J., A. Conti, and W. Pierpaoli. 1986. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. Journal of Neuroimmunology 13: 19–30.CrossRefPubMed Maestroni, G.J., A. Conti, and W. Pierpaoli. 1986. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. Journal of Neuroimmunology 13: 19–30.CrossRefPubMed
43.
go back to reference Poon, A.M., Z.M. Liu, C.S. Pang, G.M. Brown, and S.F. Pang. 1994. Evidence for a direct action of melatonin on the immune system. Biological Signals 3: 107–117.CrossRefPubMed Poon, A.M., Z.M. Liu, C.S. Pang, G.M. Brown, and S.F. Pang. 1994. Evidence for a direct action of melatonin on the immune system. Biological Signals 3: 107–117.CrossRefPubMed
44.
go back to reference Roles, V., A. Malan, M.C. Rettori, P. Delagrange, J.P. Jeanniot, and P. Pévet. 1998. Daily variations in pineal melatonin concentrations in inbred and outbred mice. Journal of Biological Rhythms 13: 403–409.CrossRef Roles, V., A. Malan, M.C. Rettori, P. Delagrange, J.P. Jeanniot, and P. Pévet. 1998. Daily variations in pineal melatonin concentrations in inbred and outbred mice. Journal of Biological Rhythms 13: 403–409.CrossRef
45.
go back to reference Jackson, C.R., M. Capozzi, H. Dai, and D.G. McMahon. 2014. Circadian perinatal photoperiod has enduring effects on retinal dopamine and visual function. Journal of Neuroscience 34: 4627–4633.CrossRefPubMedPubMedCentral Jackson, C.R., M. Capozzi, H. Dai, and D.G. McMahon. 2014. Circadian perinatal photoperiod has enduring effects on retinal dopamine and visual function. Journal of Neuroscience 34: 4627–4633.CrossRefPubMedPubMedCentral
46.
go back to reference Carrillo-Vico, A., R.J. Reiter, P.J. Lardone, J. Herrera, R. Fernández-Montesinos, and J. Guerrero. 2006. The modulatory role of melatonin on immune responsiveness. Current Opinion and Investigation in Drugs 7: 423–431. Carrillo-Vico, A., R.J. Reiter, P.J. Lardone, J. Herrera, R. Fernández-Montesinos, and J. Guerrero. 2006. The modulatory role of melatonin on immune responsiveness. Current Opinion and Investigation in Drugs 7: 423–431.
47.
go back to reference Cheung, R.T. 2003. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. Journal of Pineal Research 34: 153–160.CrossRefPubMed Cheung, R.T. 2003. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. Journal of Pineal Research 34: 153–160.CrossRefPubMed
48.
go back to reference Carrey, N., M.P. McFadyen, and R.E. Brown. 2000. Effects of subchronic methylphenidate hydrochloride administration on the locomotor and exploratory behavior of prepubertal mice. Journal of Child and Adolescent Psychopharmacology 10: 277–286.CrossRefPubMed Carrey, N., M.P. McFadyen, and R.E. Brown. 2000. Effects of subchronic methylphenidate hydrochloride administration on the locomotor and exploratory behavior of prepubertal mice. Journal of Child and Adolescent Psychopharmacology 10: 277–286.CrossRefPubMed
49.
go back to reference Mal, P., S. Dutta, D. Bandyopadhyay, K. Dutta, A. Basu, and B. Bishayi. 2012. Gentamicin in combination with ascorbic acid regulates the severity of Staphylococcus aureus infection-induced septic arthritis in mice. Scandinavian Journal of Immunology 76: 528–540.CrossRefPubMed Mal, P., S. Dutta, D. Bandyopadhyay, K. Dutta, A. Basu, and B. Bishayi. 2012. Gentamicin in combination with ascorbic acid regulates the severity of Staphylococcus aureus infection-induced septic arthritis in mice. Scandinavian Journal of Immunology 76: 528–540.CrossRefPubMed
50.
go back to reference Mahanti, S., A. Majhi, S. Chongdar, K. Kundu, K. Dutta, A. Basu, and B. Bishayi. 2013. Increased resistance of immobilized-stressed mice to infection: correlation with behavioral alterations. Brain Behaviour Immunity 28: 115–127.CrossRef Mahanti, S., A. Majhi, S. Chongdar, K. Kundu, K. Dutta, A. Basu, and B. Bishayi. 2013. Increased resistance of immobilized-stressed mice to infection: correlation with behavioral alterations. Brain Behaviour Immunity 28: 115–127.CrossRef
51.
go back to reference Mal, P., K. Dutta, D. Bandyopadhyay, A. Basu, R. Khan, and B. Bishayi. 2013. Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines. Inflammation Research 62: 259–273.CrossRefPubMed Mal, P., K. Dutta, D. Bandyopadhyay, A. Basu, R. Khan, and B. Bishayi. 2013. Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines. Inflammation Research 62: 259–273.CrossRefPubMed
52.
go back to reference Majumdar, S., K. Dutta, S.K. Manna, A. Basu, and B. Bishayi. 2011. Possible protective role of chloramphenicol in TSST-1 and coagulase-positive Staphylococcus aureus-induced septic arthritis with altered levels of inflammatory mediators. Inflammation 34: 269–282.CrossRefPubMed Majumdar, S., K. Dutta, S.K. Manna, A. Basu, and B. Bishayi. 2011. Possible protective role of chloramphenicol in TSST-1 and coagulase-positive Staphylococcus aureus-induced septic arthritis with altered levels of inflammatory mediators. Inflammation 34: 269–282.CrossRefPubMed
53.
go back to reference Chattopadhyay, A., S. Biswas, D. Bandyopadhyay, C. Sarkar, and A.G. Datta. 2003. Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine. Molecular and Cellular Biochemistry 245: 43–49.CrossRefPubMed Chattopadhyay, A., S. Biswas, D. Bandyopadhyay, C. Sarkar, and A.G. Datta. 2003. Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine. Molecular and Cellular Biochemistry 245: 43–49.CrossRefPubMed
54.
go back to reference Sedlak, J., and R.H. Lindsay. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Annals of Biochemistry 25: 192–205.CrossRef Sedlak, J., and R.H. Lindsay. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Annals of Biochemistry 25: 192–205.CrossRef
55.
go back to reference Dutta, K., D. Nandi, and B. Bishayi. 2009. Repeated systemic Escherichia coli infection enhances anti-oxidant response in hypercholesterolemic mice inducing cardiovascular inflammation. Inflammation 32: 89–98.CrossRefPubMed Dutta, K., D. Nandi, and B. Bishayi. 2009. Repeated systemic Escherichia coli infection enhances anti-oxidant response in hypercholesterolemic mice inducing cardiovascular inflammation. Inflammation 32: 89–98.CrossRefPubMed
56.
go back to reference Bishayi, B., D. Bandyopadhyay, A. Majhi, and R. Adhikary. 2015. Effect of exogenous MCP-1 on TLR-2 neutralized murine macrophages and possible mechanisms of CCR-2/TLR-2 and MCP-1 signalling during Staphylococcus aureus infection. Immunobiology 220: 350–362.CrossRefPubMed Bishayi, B., D. Bandyopadhyay, A. Majhi, and R. Adhikary. 2015. Effect of exogenous MCP-1 on TLR-2 neutralized murine macrophages and possible mechanisms of CCR-2/TLR-2 and MCP-1 signalling during Staphylococcus aureus infection. Immunobiology 220: 350–362.CrossRefPubMed
57.
go back to reference Bishayi, B., D. Bandyopadhyay, A. Majhi, and R. Adhikary. 2014. Expression of CXCR1 (interleukin-8 receptor) in murine macrophages after Staphylococcus aureus infection and its possible implication on intracellular survival correlating with cytokines and bacterial anti-oxidant enzymes. Inflammation 38: 812–827.CrossRef Bishayi, B., D. Bandyopadhyay, A. Majhi, and R. Adhikary. 2014. Expression of CXCR1 (interleukin-8 receptor) in murine macrophages after Staphylococcus aureus infection and its possible implication on intracellular survival correlating with cytokines and bacterial anti-oxidant enzymes. Inflammation 38: 812–827.CrossRef
58.
go back to reference Ghosh, C., and B. Bishayi. 2015. Toll-like receptor 2 and 6 interdependency in the erosive stage of Staphylococcus aureus induced septic arthritis mediated by IFN-γ and IL-6-A possible involvement of IL-17 in the progression of the disease. Immunobiology 220: 910–923.CrossRefPubMed Ghosh, C., and B. Bishayi. 2015. Toll-like receptor 2 and 6 interdependency in the erosive stage of Staphylococcus aureus induced septic arthritis mediated by IFN-γ and IL-6-A possible involvement of IL-17 in the progression of the disease. Immunobiology 220: 910–923.CrossRefPubMed
59.
go back to reference Silvestri, M., and G.A. Rossi. 2013. Melatonin: its possible role in the management of viral infections—a brief review. Italian Journal of Pediatrics 39: 61.CrossRefPubMedPubMedCentral Silvestri, M., and G.A. Rossi. 2013. Melatonin: its possible role in the management of viral infections—a brief review. Italian Journal of Pediatrics 39: 61.CrossRefPubMedPubMedCentral
60.
go back to reference Wehr, T.A. 2001. Photoperiodism in humans and other primates: evidence and implications. Journal of Biological Rhythms 16: 348–364.CrossRefPubMed Wehr, T.A. 2001. Photoperiodism in humans and other primates: evidence and implications. Journal of Biological Rhythms 16: 348–364.CrossRefPubMed
61.
go back to reference Lewy, A.J., T.A. Wehr, F.K. Goodwin, D.A. Newsome, and S.P. Markey. 2010. Light suppresses melatonin secretion in humans. Science 210: 1267–1269.CrossRef Lewy, A.J., T.A. Wehr, F.K. Goodwin, D.A. Newsome, and S.P. Markey. 2010. Light suppresses melatonin secretion in humans. Science 210: 1267–1269.CrossRef
62.
go back to reference Lewy, A.J., V.K. Bauer, and S. Ahmed. 1998. The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiology International 15: 71–83.CrossRefPubMed Lewy, A.J., V.K. Bauer, and S. Ahmed. 1998. The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiology International 15: 71–83.CrossRefPubMed
63.
go back to reference Haginoya, K., M. Ishitobi, N. Togashi, M. Munakata, H. Yokoyama, and K. Inuma. 2004. High dose melatonin therapy for patients with extremely intractable epilepsy. Neurology Asia 9: 114. Haginoya, K., M. Ishitobi, N. Togashi, M. Munakata, H. Yokoyama, and K. Inuma. 2004. High dose melatonin therapy for patients with extremely intractable epilepsy. Neurology Asia 9: 114.
64.
go back to reference Reiter, R.J., D.X. Tan, T.S. Herman, and C.R. Thomas Jr. 2004. Melatonin as a radioprotective agent: a review. International Journal of Radiation Oncology, Biology, Physics 59: 639–653.CrossRefPubMed Reiter, R.J., D.X. Tan, T.S. Herman, and C.R. Thomas Jr. 2004. Melatonin as a radioprotective agent: a review. International Journal of Radiation Oncology, Biology, Physics 59: 639–653.CrossRefPubMed
66.
go back to reference Rapozzi, V., L. Perissin, S. Zorzet, and T. Giraldi. 1992. Effects of melatonin administration on tumor spread in mice bearing Lewis lung carcinoma. Pharmacological Research 25: 71–72.CrossRefPubMed Rapozzi, V., L. Perissin, S. Zorzet, and T. Giraldi. 1992. Effects of melatonin administration on tumor spread in mice bearing Lewis lung carcinoma. Pharmacological Research 25: 71–72.CrossRefPubMed
67.
go back to reference Giannoulia-Karantana, A., A. Vlachou, S. Polychronopoulou, I. Papassotirio, and G. Chrousos. 2006. Melatonin and immunomodulation: connections and potential clinical applications. Neuroimmunomodulation 13: 133–144.CrossRefPubMed Giannoulia-Karantana, A., A. Vlachou, S. Polychronopoulou, I. Papassotirio, and G. Chrousos. 2006. Melatonin and immunomodulation: connections and potential clinical applications. Neuroimmunomodulation 13: 133–144.CrossRefPubMed
68.
go back to reference Pitrosky, B., R. Kirsch, A. Malan, E. Mocaer, and P. Pevet. 1999. Organization of rat circadian rhythms during daily infusion of melatonin or S20098, a melatonin agonist. American Journal of Physiology 277: 812–828. Pitrosky, B., R. Kirsch, A. Malan, E. Mocaer, and P. Pevet. 1999. Organization of rat circadian rhythms during daily infusion of melatonin or S20098, a melatonin agonist. American Journal of Physiology 277: 812–828.
69.
go back to reference França, E., A. Junior, S. de Oliveira, and A. Honório-França. 2008. Chronoimmunomodulation of melatonin on bactericidal activity of human blood phagocytes. Internet Journal of Microbiology 6: 1–6. França, E., A. Junior, S. de Oliveira, and A. Honório-França. 2008. Chronoimmunomodulation of melatonin on bactericidal activity of human blood phagocytes. Internet Journal of Microbiology 6: 1–6.
70.
go back to reference Sacco, S., L. Aquilini, P. Ghezzi, M. Pinza, and A. Guglielmotti. 1998. Mechanism of the inhibitory effect of melatonin on tumor necrosis factor production in vivo and in vitro. European Journal of Pharmacology 343: 249–255.CrossRefPubMed Sacco, S., L. Aquilini, P. Ghezzi, M. Pinza, and A. Guglielmotti. 1998. Mechanism of the inhibitory effect of melatonin on tumor necrosis factor production in vivo and in vitro. European Journal of Pharmacology 343: 249–255.CrossRefPubMed
71.
go back to reference Moore, C.B., and T.D. Siopes. 2002. Melatonin can produce immunoenhancement in Japanese quail (Coturnixcoturnix japonica) without prior immunosuppression. General and Comparative Endocrinology 129: 122–126.CrossRefPubMed Moore, C.B., and T.D. Siopes. 2002. Melatonin can produce immunoenhancement in Japanese quail (Coturnixcoturnix japonica) without prior immunosuppression. General and Comparative Endocrinology 129: 122–126.CrossRefPubMed
72.
go back to reference Galijasevic, S., I. Abdulhamid, and H.M. Abu-Soud. 2008. Melatonin is a potent inhibitor for myeloperoxidase. Biochemistry 47: 2668–2677.CrossRefPubMed Galijasevic, S., I. Abdulhamid, and H.M. Abu-Soud. 2008. Melatonin is a potent inhibitor for myeloperoxidase. Biochemistry 47: 2668–2677.CrossRefPubMed
73.
go back to reference Shin, I.S., N.R. Shin, J.W. Park, C.M. Jeon, J.M. Hong, and O.K. Kwon. 2015. Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via the suppression of Erk-Sp1 signaling. Journal of Pineal Research 58: 50–60.CrossRefPubMed Shin, I.S., N.R. Shin, J.W. Park, C.M. Jeon, J.M. Hong, and O.K. Kwon. 2015. Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via the suppression of Erk-Sp1 signaling. Journal of Pineal Research 58: 50–60.CrossRefPubMed
74.
go back to reference Schultz, C.L., T.S. Edrington, T.R. Callaway, S.B. Schroeder, D.M. Hallford, K.J. Genovese, R.C. Anderson, and D.J. Nisbet. 2006. The influence of melatonin on growth of E. coli O157:H7 in pure culture and exogenous melatonin on faecal shedding of E. coli O157:H7 in experimentally infected wethers. Letters in Applied Microbiology 43: 105–110.CrossRefPubMed Schultz, C.L., T.S. Edrington, T.R. Callaway, S.B. Schroeder, D.M. Hallford, K.J. Genovese, R.C. Anderson, and D.J. Nisbet. 2006. The influence of melatonin on growth of E. coli O157:H7 in pure culture and exogenous melatonin on faecal shedding of E. coli O157:H7 in experimentally infected wethers. Letters in Applied Microbiology 43: 105–110.CrossRefPubMed
75.
go back to reference Malpaux, B., M. Migaud, H. Tricoire, and P. Chemineau. 2001. Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin. Journal of Biological Rhythms 16: 336–347.CrossRefPubMed Malpaux, B., M. Migaud, H. Tricoire, and P. Chemineau. 2001. Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin. Journal of Biological Rhythms 16: 336–347.CrossRefPubMed
76.
go back to reference Rodriguez, C., J.C. Mayo, R.M. Sainz, I. Antolín, F. Herrera, V. Martín, and R.J. Reiter. 2004. Regulation of antioxidant enzymes: a significant role for melatonin. Journal of Pineal Research 36: 1–9.CrossRefPubMed Rodriguez, C., J.C. Mayo, R.M. Sainz, I. Antolín, F. Herrera, V. Martín, and R.J. Reiter. 2004. Regulation of antioxidant enzymes: a significant role for melatonin. Journal of Pineal Research 36: 1–9.CrossRefPubMed
77.
go back to reference Tan, D.X., L.C. Manchester, R.J. Reiter, B.F. Plummer, J. Limson, S.T. Weintraub, and W. Qi. 2000. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radical Biology and Medicine 29: 1177–1185.CrossRefPubMed Tan, D.X., L.C. Manchester, R.J. Reiter, B.F. Plummer, J. Limson, S.T. Weintraub, and W. Qi. 2000. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radical Biology and Medicine 29: 1177–1185.CrossRefPubMed
78.
go back to reference Ding, K., H. Wang, J. Xu, T. Li, L. Zhang, Y. Ding, L. Zhu, J. He, and M. Zhuo. 2014. Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism. Free Radical Biology and Medicine 73: 1–11.CrossRefPubMed Ding, K., H. Wang, J. Xu, T. Li, L. Zhang, Y. Ding, L. Zhu, J. He, and M. Zhuo. 2014. Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: the Nrf2-ARE signaling pathway as a potential mechanism. Free Radical Biology and Medicine 73: 1–11.CrossRefPubMed
79.
go back to reference Laliena, A., B.S. Miguel, I. Crespo, M. Alvarez, J. González-Gallego, and M.J. Tuñón. 2012. Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin. Journal of Pineal Research 53: 270–278.CrossRefPubMed Laliena, A., B.S. Miguel, I. Crespo, M. Alvarez, J. González-Gallego, and M.J. Tuñón. 2012. Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin. Journal of Pineal Research 53: 270–278.CrossRefPubMed
80.
go back to reference Kim, J.Y., Y.D. Lee, B.J. Kim, S.P. Kim, D.H. Kim, K.J. Jo, S.K. Lee, K.H. Lee, and H.W. Baik. 2012. Melatonin improves inflammatory cytokine profiles in lung inflammation associated with sleep deprivation. Molecular Medicine Reports 5: 1281–1284.PubMed Kim, J.Y., Y.D. Lee, B.J. Kim, S.P. Kim, D.H. Kim, K.J. Jo, S.K. Lee, K.H. Lee, and H.W. Baik. 2012. Melatonin improves inflammatory cytokine profiles in lung inflammation associated with sleep deprivation. Molecular Medicine Reports 5: 1281–1284.PubMed
81.
go back to reference Raghavendra, V., V. Singh, S.K. Kulkarni, and J.N. Agrewala. 2001. Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Molecular and Cellular Biochemistry 221: 57–62.CrossRefPubMed Raghavendra, V., V. Singh, S.K. Kulkarni, and J.N. Agrewala. 2001. Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Molecular and Cellular Biochemistry 221: 57–62.CrossRefPubMed
82.
go back to reference Reiter, R.J., D.X. Tan, and L. Fuentes-Broto. 2010. Melatonin: a multitasking molecule. Progress in Brain Research 181: 127–151.CrossRefPubMed Reiter, R.J., D.X. Tan, and L. Fuentes-Broto. 2010. Melatonin: a multitasking molecule. Progress in Brain Research 181: 127–151.CrossRefPubMed
83.
go back to reference Black, S., I. Kushner, and D. Samols. 2004. C-reactive protein. Journal of Biological Chemistry 279: 48487–48490.CrossRefPubMed Black, S., I. Kushner, and D. Samols. 2004. C-reactive protein. Journal of Biological Chemistry 279: 48487–48490.CrossRefPubMed
84.
go back to reference Anwar, J., B.Y. Muhammad, A.A. Bader, M. Mahfoudh Abdulghani, D. Mahmood, and M. Haider. 2015. An insight into the scientific background and future perspectives for the potential uses of melatonin. Egyptian Journal of Basic Applied Sciences 2: 139–152.CrossRef Anwar, J., B.Y. Muhammad, A.A. Bader, M. Mahfoudh Abdulghani, D. Mahmood, and M. Haider. 2015. An insight into the scientific background and future perspectives for the potential uses of melatonin. Egyptian Journal of Basic Applied Sciences 2: 139–152.CrossRef
85.
go back to reference Hastings, M.H., E.S. Maywood, and A.B. Reddy. 2008. Two decades of circadian time. Journal of Neuroendocrinology 28: 812–819.CrossRef Hastings, M.H., E.S. Maywood, and A.B. Reddy. 2008. Two decades of circadian time. Journal of Neuroendocrinology 28: 812–819.CrossRef
86.
go back to reference Zaitone, S.A., L.N. Hammad, and N.E. Farag. 2013. Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice. Pharmacological Reports 65: 1213–1226.CrossRefPubMed Zaitone, S.A., L.N. Hammad, and N.E. Farag. 2013. Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice. Pharmacological Reports 65: 1213–1226.CrossRefPubMed
87.
go back to reference Zhang, L., H.Q. Zhang, X.Y. Liang, H.F. Zhang, T. Zhang, and F.E. Liu. 2013. Melatonin ameliorates cognitive impairment induced by sleep deprivation in rats: role of oxidative stress, BDNF and CaMKII. Behavioral Brain Research 256: 2–81.CrossRef Zhang, L., H.Q. Zhang, X.Y. Liang, H.F. Zhang, T. Zhang, and F.E. Liu. 2013. Melatonin ameliorates cognitive impairment induced by sleep deprivation in rats: role of oxidative stress, BDNF and CaMKII. Behavioral Brain Research 256: 2–81.CrossRef
88.
go back to reference Mohammadghasemi, F., S.K. Jahromi, H. Hajizadeh, M.A. Homafar, and N. Saadat. 2012. The protective effects of exogenous melatonin on nicotine-induced changes in mouse ovarian follicles. Journal of Reproduction and Infertility 13: 143–150.PubMedPubMedCentral Mohammadghasemi, F., S.K. Jahromi, H. Hajizadeh, M.A. Homafar, and N. Saadat. 2012. The protective effects of exogenous melatonin on nicotine-induced changes in mouse ovarian follicles. Journal of Reproduction and Infertility 13: 143–150.PubMedPubMedCentral
89.
go back to reference Nelson, R.J., G.E. Demas, S.L. Klein, and L.J. Kriegsfeld. 1995. The influence of season, photoperiod, and pineal melatonin on immune function. Journal of Pineal Research 19: 149–165.CrossRefPubMed Nelson, R.J., G.E. Demas, S.L. Klein, and L.J. Kriegsfeld. 1995. The influence of season, photoperiod, and pineal melatonin on immune function. Journal of Pineal Research 19: 149–165.CrossRefPubMed
90.
go back to reference Nunnari, G., L. Nigro, F. Palermo, D. Leto, R.J. Pomerantz, and B. Cacopardo. 2003. Reduction of serum melatonin levels in HIV-1-infected individuals’ parallel disease progression: correlation with serum interleukin-12 levels. Infection 31: 379–382.PubMed Nunnari, G., L. Nigro, F. Palermo, D. Leto, R.J. Pomerantz, and B. Cacopardo. 2003. Reduction of serum melatonin levels in HIV-1-infected individuals’ parallel disease progression: correlation with serum interleukin-12 levels. Infection 31: 379–382.PubMed
91.
go back to reference Arendt, J. 2010. Shift work: coping with the biological clock. Occupational Medicine (London) 60: 10–20.CrossRef Arendt, J. 2010. Shift work: coping with the biological clock. Occupational Medicine (London) 60: 10–20.CrossRef
92.
go back to reference Hansson, I., R. Holmdahl, and R. Mattsson. 1992. The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice. Journal of Neuroimmunology 39: 23–30.CrossRefPubMed Hansson, I., R. Holmdahl, and R. Mattsson. 1992. The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice. Journal of Neuroimmunology 39: 23–30.CrossRefPubMed
93.
go back to reference Constantinescu, C.S., B. Hilliard, E. Ventura, and A. Rostami. 1997. Luzindole, a melatonin receptor antagonist, suppresses experimental autoimmune encephalomyelitis. Pathobiology 6: 190–194.CrossRef Constantinescu, C.S., B. Hilliard, E. Ventura, and A. Rostami. 1997. Luzindole, a melatonin receptor antagonist, suppresses experimental autoimmune encephalomyelitis. Pathobiology 6: 190–194.CrossRef
Metadata
Title
Beneficial Effects of Exogenous Melatonin in Acute Staphylococcus aureus and Escherichia coli Infection-Induced Inflammation and Associated Behavioral Response in Mice After Exposure to Short Photoperiod
Authors
Biswadev Bishayi
Rana Adhikary
Ajeya Nandi
Sahin Sultana
Publication date
01-12-2016
Publisher
Springer US
Published in
Inflammation / Issue 6/2016
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0445-9

Other articles of this Issue 6/2016

Inflammation 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.